These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19190247)

  • 1. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
    Lucas DM; Edwards RB; Lozanski G; West DA; Shin JD; Vargo MA; Davis ME; Rozewski DM; Johnson AJ; Su BN; Goettl VM; Heerema NA; Lin TS; Lehman A; Zhang X; Jarjoura D; Newman DJ; Byrd JC; Kinghorn AD; Grever MR
    Blood; 2009 May; 113(19):4656-66. PubMed ID: 19190247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
    Liu Q; Zhao X; Frissora F; Ma Y; Santhanam R; Jarjoura D; Lehman A; Perrotti D; Chen CS; Dalton JT; Muthusamy N; Byrd JC
    Blood; 2008 Jan; 111(1):275-84. PubMed ID: 17761520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    de Frias M; Iglesias-Serret D; Cosialls AM; Coll-Mulet L; Santidrián AF; González-Gironès DM; de la Banda E; Pons G; Gil J
    Haematologica; 2009 Dec; 94(12):1698-707. PubMed ID: 19815839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.
    Chen R; Guo L; Chen Y; Jiang Y; Wierda WG; Plunkett W
    Blood; 2011 Jan; 117(1):156-64. PubMed ID: 20971952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
    Alinari L; Prince CJ; Edwards RB; Towns WH; Mani R; Lehman A; Zhang X; Jarjoura D; Pan L; Kinghorn AD; Grever MR; Baiocchi RA; Lucas DM
    Clin Cancer Res; 2012 Sep; 18(17):4600-11. PubMed ID: 22791882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia.
    Capitani N; Lucherini OM; Sozzi E; Ferro M; Giommoni N; Finetti F; De Falco G; Cencini E; Raspadori D; Pelicci PG; Lauria F; Forconi F; Baldari CT
    Blood; 2010 May; 115(18):3726-36. PubMed ID: 20061561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
    Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
    Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells.
    Wilmore S; Rogers-Broadway KR; Taylor J; Lemm E; Fell R; Stevenson FK; Forconi F; Steele AJ; Coldwell M; Packham G; Yeomans A
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6337-6349. PubMed ID: 34398253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria.
    Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
    Nutr Cancer; 2016; 68(8):1404-1416. PubMed ID: 27779444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
    McCarthy BA; Boyle E; Wang XP; Guzowski D; Paul S; Catera R; Trott J; Yan XJ; Croce CM; Damle R; Yancopoulos S; Messmer BT; Lesser M; Allen SL; Rai KR; Chiorazzi N
    Mol Med; 2008; 14(9-10):618-27. PubMed ID: 18633450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
    Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
    PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia.
    Chen R; Zhu M; Chaudhari RR; Robles O; Chen Y; Skillern W; Qin Q; Wierda WG; Zhang S; Hull KG; Romo D; Plunkett W
    Leukemia; 2019 Jul; 33(7):1663-1674. PubMed ID: 30700841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
    Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
    Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.
    Balakrishnan K; Burger JA; Quiroga MP; Henneberg M; Ayres ML; Wierda WG; Gandhi V
    Blood; 2010 Aug; 116(7):1083-91. PubMed ID: 20442367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
    Merkel O; Wacht N; Sifft E; Melchardt T; Hamacher F; Kocher T; Denk U; Hofbauer JP; Egle A; Scheideler M; Schlederer M; Steurer M; Kenner L; Greil R
    Leukemia; 2012 Dec; 26(12):2508-16. PubMed ID: 22743622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
    Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
    Salimi A; Motallebi A; Ayatollahi M; Seydi E; Mohseni AR; Nazemi M; Pourahmad J
    Environ Toxicol; 2017 Apr; 32(4):1158-1169. PubMed ID: 27404045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells.
    Gupta SV; Sass EJ; Davis ME; Edwards RB; Lozanski G; Heerema NA; Lehman A; Zhang X; Jarjoura D; Byrd JC; Pan L; Chan KK; Kinghorn AD; Phelps MA; Grever MR; Lucas DM
    AAPS J; 2011 Sep; 13(3):357-64. PubMed ID: 21538216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
    Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
    Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.